9975 Summers Ridge Road
San Diego, CA 92121
United States
858-552-1100
https://www.quidelortho.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 1600
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Douglas C. Bryant | Chairman & CEO | 1,41M | N/A | 1958 |
Mr. Robert J. Bujarski J.D. | Pres & COO | 770,62k | N/A | 1969 |
Ms. Michelle A. Hodges | Gen. Counsel | 620,61k | N/A | 1960 |
Dr. Werner Kroll Ph.D. | Sr. VP of R&D | 758,22k | 2,1M | 1957 |
Mr. Joseph M. Busky CPA | Chief Financial Officer | N/A | N/A | 1968 |
Ruben Argueta | Director of Investor Relations | N/A | N/A | N/A |
Mr. Michael S. Iskra | Chief Commercial Officer | N/A | N/A | 1970 |
Phillip S. Askim | VP, Associate Gen. Counsel & Sec. | N/A | N/A | N/A |
Dr. Johannes Kehle | Pres of AnDiaTec Division | N/A | N/A | N/A |
Mr. Rhys de Callier | VP of Strategy & Portfolio Management | N/A | N/A | N/A |
QuidelOrtho Corporation provides various in vitro diagnostics products worldwide. The company's product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and clinical and at-home products to detect COVID-19. It provides visually-read lateral flow products in infectious disease and reproductive health; direct fluorescent antibodies in infectious disease and virology; micro-titer production with a focus on bone and complement pathway markets; fluorescent immunoassay products; molecular diagnostic products comprising Savanna, an integrated molecular diagnostic system; immunodiagnostics, clinical chemistry, and integrated testing systems to serve diagnostic labs of all sizes; immunodiagnostic donor screening systems and services that drive blood safety; pre-transfusion testing that automates blood bank workload with software to standardize operations, simplify tasks, and improve productivity; and Ortho Care services and informatics products. The company was founded in 1979 and is headquartered in San Diego, California.
El ISS Governance QualityScore de QuidelOrtho Corporation, a día 1 de julio de 2022, es 4. Las puntuaciones base son Auditoría: 8; Tablero: 3; Derechos de los accionistas: 3; Compensación: 4.